Recent strategic research and analysis
Getting to the bottom of alliance failure rates
Nearly fifty percent of alliances 'fail'. Right? Well no actually.
BioPartnering 2008
The terms of a deal on offer, a partner's development expertise and their alliance management skills are the top drivers of alliance formation according to senior partnering business development executives in the pharmaceutical, biotechnology and medical devices industry and research institutes who participated in the BioPartnering 2008 survey.
Alliances drive the hunt for clean energy
Motor companies looking to perfect hybrid and plug-in electric cars as the solution to soaring oil costs and concerns about the environment see alliances as the way forward.
The impact of large alliances on share prices
Do alliances and partnerships really detract from the market value of biotechnology companies?
Funding research and development through spin-outs
In a bid to cut costs AstraZeneca is spinning out its efforts to find new drugs for gastrointestinal (GI) disorders to a new company called Albireo. Part of the decision reflects AztraZeneca's recent problems with its drug, Nexium, an ulcer treatment, which has been declining in profit and its decision to direct its energies on respiratory, cancer and infectious diseases.
Pfizer invests in web-based software company
Why is Pfizer so heavily behind a struggling web-based software company operating in a crowded space?
Life science companies optimistic about 2008
A recent survey by Silico Research has revealed that executives in life science companies are optimistic about the prospects for their industry going into 2008.
Latest research on the top patent lawyers
Silico Research's analysis of over 40,000 patents and applications filed at the USPTO in the life sciences and selected IT areas between 1995-2007 has shown that the California-based firm Townsend and Townsend and Crew LLP was the leading patent firm when measured by the number of patents and applications filed.
Public-private partnerships for drug development: An emerging trend or special cases?
On November 5th 2007 the pharmaceutical company GlaxoSmithKline announced that it had formed a five year alliance with the Texan based non-profit research institution MD Anderson Cancer Center to discover and develop new therapeutic, diagnostic and imaging products for cancer.
Yahoo! leads Amazon, Google and eBay, in patents at least
Despite all the noise made by Amazon's one click patent, Yahoo!, with 707 patents and applications filed, has pursued a far more aggressive patenting strategy than Amazon, eBay or Google. These figures include patents subsequently acquired by the major companies through acquisitions.
|| 
